Primary Site >> Liver Cancer

Gene >> ALPK2

Journal: Hepatology. 1993 Aug;18(2):320-7.
Title: Establishment of two distinct human hepatocellular carcinoma cell lines from a single nodule showing clonal dedifferentiation of cancer cells.
Author: Yano, H|Iemura, A|Fukuda, K|Mizoguchi, A|Haramaki, M|Kojiro, M
PMID: 8393423
Journal: Hepatology. 1995 May;21(5):1276-84.
Title: Expression of CD44 in human hepatocellular carcinoma cell lines.
Author: Haramaki, M|Yano, H|Fukuda, K|Momosaki, S|Ogasawara, S|Kojiro, M
PMID: 7537711
Journal: Hepatology. 1996 Jul;24(1):198-205.
Title: Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines.
Author: Ogasawara, S|Yano, H|Iemura, A|Hisaka, T|Kojiro, M
PMID: 8707262
Journal: Hum Cell. 1997 Sep;10(3):183-92.
Title: A new human hepatocellular carcinoma cell line (HAK-2) forms various structures in collagen gel matrices.
Author: Haramaki, M|Yano, H|Iemura, A|Momosaki, S|Ogasawara, S|Inoue, M|Yamaguchi, R|Kusaba, A|Utsunomiya, I|Kojiro, M
PMID: 9436038
Journal: Int J Oncol. 1999 Oct;15(4):669-75.
Title: Establishment and characterization of a new human hepatocellular carcinoma cell line, HAK-3, and its response to growth factors.
Author: Utsunomiya, I|Iemura, A|Yano, H|Akiba, J|Kojiro, M
PMID: 10493947
Journal: Hepatology. 2001 May;33(5):1087-97.
Title: Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Author: Koga, H|Sakisaka, S|Harada, M|Takagi, T|Hanada, S|Taniguchi, E|Kawaguchi, T|Sasatomi, K|Kimura, R|Hashimoto, O|Ueno, T|Yano, H|Kojiro, M|Sata, M
PMID: 11343236
Journal: Hepatol Res. 2002 Oct;24(2):99.
Title: Different antiviral activities of IFN-alpha subtypes in human liver cell lines: synergism between IFN-alpha2 and IFN-alpha8.
Author: Yamamoto, Shigeto|Yano, Hirohisa|Sanou, Osamu|Ikegami, Hakuo|Kurimoto, Masashi|Kojiro, Masamichi
PMID: 12270738
Journal: J Hepatol. 2004 Nov;41(5):782-9.
Title: Interferon-alphaCon1 suppresses proliferation of liver cancer cell lines in vitro and in vivo.
Author: Hisaka, Toru|Yano, Hirohisa|Ogasawara, Sachiko|Momosaki, Seiya|Nishida, Naoyo|Takemoto, Yumi|Kojiro, Sakiko|Katafuchi, Yuno|Kojiro, Masamichi
PMID: 15519651
Journal: J Gastroenterol Hepatol. 2006 Nov;21(11):1720-5.
Title: Growth inhibitory effects of interferon-alpha subtypes vary according to human liver cancer cell lines.
Author: Yano, Hirohisa|Yanai, Yoshiaki|Momosaki, Seiya|Ogasawara, Sachiko|Akiba, Jun|Kojiro, Sakiko|Moriya, Fukuko|Fukahori, Suguru|Kurimoto, Masashi|Kojiro, Masamichi
PMID: 16984596
Journal: Cancer Sci. 2006 Nov;97(11):1182-90.
Title: High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma.
Author: Aishima, Shinichi|Basaki, Yuji|Oda, Yoshinao|Kuroda, Yousuke|Nishihara, Yunosuke|Taguchi, Kenichi|Taketomi, Akinobu|Maehara, Yoshihiko|Hosoi, Fumihito|Maruyama, Yuichiro|Fotovati, Abbas|Oie, Shinji|Ono, Mayumi|Ueno, Takato|Sata, Michio|Yano, Hirohisa|Koji
PMID: 16965600
Journal: Liver Int. 2006 Oct;26(8):964-75.
Title: Growth inhibitory effects of pegylated IFN alpha-2b on human liver cancer cells in vitro and in vivo.
Author: Yano, Hirohisa|Ogasawara, Sachiko|Momosaki, Seiya|Akiba, Jun|Kojiro, Sakiko|Fukahori, Suguru|Ishizaki, Hironori|Kuratomi, Keitaro|Basaki, Yuji|Oie, Shinji|Kuwano, Michihiko|Kojiro, Masamichi
PMID: 16953837
Journal: J Interferon Cytokine Res. 2007 Jun;27(6):507-16.
Title: Growth inhibitory effects of IFN-beta on human liver cancer cells in vitro and in vivo.
Author: Ogasawara, Sachiko|Yano, Hirohisa|Momosaki, Seiya|Akiba, Jun|Nishida, Naoyo|Kojiro, Sakiko|Moriya, Fukuko|Ishizaki, Hironori|Kuratomi, Keitaro|Kojiro, Masamichi
PMID: 17572015
Journal: Mol Cancer Ther. 2007 Aug;6(8):2310-8.
Title: Alteration of dihydropyrimidine dehydrogenase expression by IFN-alpha affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells.
Author: Oie, Shinji|Ono, Mayumi|Fukushima, Hiroto|Hosoi, Fumihito|Yano, Hirohisa|Maruyama, Yuichiro|Kojiro, Masamichi|Terada, Tadafumi|Hirano, Kazuyuki|Kuwano, Michihiko|Yamada, Yuji
PMID: 17699726
Journal: Cancer Lett. 2011 Nov 1;310(1):25-34.
Title: N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase.
Author: Akiba, Jun|Murakami, Yuichi|Noda, Masaki|Watari, Kosuke|Ogasawara, Sachiko|Yoshida, Takafumi|Kawahara, Akihiko|Sanada, Sakiko|Yasumoto, Makiko|Yamaguchi, Rin|Kage, Masayoshi|Kuwano, Michihiko|Ono, Mayumi|Yano, Hirohisa
PMID: 21775055
Journal: Int J Oncol. 2013 Jun;42(6):1897-903.
Title: Antiproliferative effects of sorafenib and pegylated IFNalpha2b on human liver cancer cells in vitro and in vivo.
Author: Kusano, Hironori|Ogasawara, Sachiko|Akiba, Jun|Nakayama, Masamichi|Ueda, Kosuke|Yano, Hirohisa
PMID: 23588838
Journal: Liver Int. 2013 Nov;33(10):1536-48.
Title: Loss of exon 4 in a human T-cell factor-4 isoform promotes hepatic tumourigenicity.
Author: Tomimaru, Yoshito|Xu, Chelsea Q|Nambotin, Sarah B|Yan, Tao|Wands, Jack R|Kim, Miran
PMID: 23648141
Journal: PLoS One. 2013 Dec 12;8(12):e83195.
Title: Pegylated interferon-alpha2a inhibits proliferation of human liver cancer cells in vitro and in vivo.
Author: Kusano, Hironori|Akiba, Jun|Ogasawara, Sachiko|Sanada, Sakiko|Yasumoto, Makiko|Nakayama, Masamichi|Ueda, Keiko|Ueda, Kosuke|Kurita, Takashi|Todoroki, Keita|Umeno, Yumi|Nakashima, Osamu|Yano, Hirohisa
PMID: 24349459
Journal: J Gastroenterol Hepatol. 2014 May;29(5):1092-101.
Title: Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells.
Author: Nakayama, Masamichi|Ogasawara, Sachiko|Akiba, Jun|Ueda, Kosuke|Koura, Keiko|Todoroki, Keita|Kinoshita, Hisafumi|Yano, Hirohisa
PMID: 24325739
Journal: Oncotarget. 2016 Jul 26;7(30):47403-47417.
Title: Phosphorylation of mTOR Ser2481 is a key target limiting the efficacy of rapalogs for treating hepatocellular carcinoma.
Author: Watari, Kosuke|Nishitani, Ayumi|Shibata, Tomohiro|Noda, Masaki|Kawahara, Akihiko|Akiba, Jun|Murakami, Yuichi|Yano, Hirohisa|Kuwano, Michihiko|Ono, Mayumi
PMID: 27329724
Journal: Cancer Sci. 2018 Sep;109(9):2801-2810.
Title: High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine.
Author: Wada, Fumitaka|Koga, Hironori|Akiba, Jun|Niizeki, Takashi|Iwamoto, Hideki|Ikezono, Yu|Nakamura, Toru|Abe, Mitsuhiko|Masuda, Atsutaka|Sakaue, Takahiko|Tanaka, Toshimitsu|Kakuma, Tatsuyuki|Yano, Hirohisa|Torimura, Takuji
PMID: 29981246